ArticleEJHaem2025
Epcoritamab for Relapsed/Refractory EBV+ Post-Transplant Lymphoproliferative Disorder of DLBCL-Type.
Li Yuan Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEJHaem2025
Li Yuan Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.